Kelly Banas

Ph.D. Candidate

B.S. University of Delaware
MLS (ASCP)CM

Kelly Banas is a fourth-year graduate student at the University of Delaware with research interests in developing and evaluating novel gene editing strategies in non-small cell lung cancer. Her current focus is on targeting cancer specific NRF2 mutations with CRISPR gene editing tools and evaluating the short and long-term effects these specific targeting strategies have on affected and neighboring cells. Kelly’s seminal discovery of a unique CRISPR target site within tumor cells in its absence normal cell surrounding the tumor, had establish an innovative foundational approach to the treatment of solid tumors by CRISPR directed gene editing. She recently been a major presentation to the FDA since her discoveries have enabled the development of a clinical protocol. She should receive her PhD in the spring of 2021.